167 related articles for article (PubMed ID: 2117388)
1. Molecular mechanisms of action of glyburide on the beta cell.
Boyd AE; Aguilar-Bryan L; Nelson DA
Am J Med; 1990 Aug; 89(2A):3S-10S; discussion 51S-53S. PubMed ID: 2117388
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea receptors, ion channels, and fruit flies.
Boyd AE
Diabetes; 1988 Jul; 37(7):847-50. PubMed ID: 2454858
[TBL] [Abstract][Full Text] [Related]
3. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
4. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
5. Sulfonylurea receptors and ATP-sensitive K+ channels in clonal pancreatic alpha cells. Evidence for two high affinity sulfonylurea receptors.
Rajan AS; Aguilar-Bryan L; Nelson DA; Nichols CG; Wechsler SW; Lechago J; Bryan J
J Biol Chem; 1993 Jul; 268(20):15221-8. PubMed ID: 8325894
[TBL] [Abstract][Full Text] [Related]
6. Do adipocytes contain high affinity sulfonylurea receptors.
Rajan AS; Luo ZT; Kahn BB; Comstock JP; Cushman SW; Boyd AE
Endocrinology; 1994 Mar; 134(3):1581-8. PubMed ID: 8119201
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
Tian YA; Johnson G; Ashcroft SJ
Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
[TBL] [Abstract][Full Text] [Related]
8. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
[TBL] [Abstract][Full Text] [Related]
10. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the sulfonylurea receptor on beta cell membranes.
Gaines KL; Hamilton S; Boyd AE
J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
[TBL] [Abstract][Full Text] [Related]
12. The beta-cell glibenclamide receptor is an ADP-binding protein.
Niki I; Nicks JL; Ashcroft SJ
Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
[TBL] [Abstract][Full Text] [Related]
13. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
[TBL] [Abstract][Full Text] [Related]
14. Sulfonylurea binding to a low-affinity site inhibits the Na/K-ATPase and the KATP channel in insulin-secreting cells.
Ribalet B; Mirell CJ; Johnson DG; Levin SR
J Gen Physiol; 1996 Feb; 107(2):231-41. PubMed ID: 8833343
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
[TBL] [Abstract][Full Text] [Related]
16. Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of beta-cells.
Schwanstecher C; Meyer M; Schwanstecher M; Panten U
Br J Pharmacol; 1998 Mar; 123(6):1023-30. PubMed ID: 9559882
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylurea signal transduction.
Boyd AE; Aguilar-Bryan L; Bryan J; Kunze DL; Moss L; Nelson DA; Rajan AS; Raef H; Xiang HD; Yaney GC
Recent Prog Horm Res; 1991; 47():299-316; discussion 316-7. PubMed ID: 1660613
[TBL] [Abstract][Full Text] [Related]
18. Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas.
Brady PA; Alekseev AE; Terzic A
Circ Res; 1998 Feb; 82(2):272-8. PubMed ID: 9468198
[TBL] [Abstract][Full Text] [Related]
19. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
20. ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
Bernardi H; De Weille JR; Epelbaum J; Mourre C; Amoroso S; Slama A; Fosset M; Lazdunski M
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1340-4. PubMed ID: 8433992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
